Trident Resources Corp. disclosed updated information about its marketing agreement with Freedom Financial Research, LLC (FFR). The company has engaged FFR to run a 30-day email-based investor awareness campaign targeting over one million retail investors, costing $150,000 paid upfront from working capital. The campaign includes eight emails distributed to FFR's subscriber lists, with all content approved by Trident. This effort aims to boost investor interest in Trident's gold exploration projects in Saskatchewan. The agreement awaits TSX Venture Exchange approval and excludes social media marketing.
Trident Resources Corp.'s marketing engagement with Freedom Financial Research, LLC is noted here with Pluang's Financials-sector market data for context. For readers following Financials-sector stocks, here is Pluang's market snapshot as of Oct 17, 2026 05:41 WIB: out of 142 priced stocks, 69 rose and 72 fell. Notable movers include GEMI at USD 3.59 with a 7.47% decline and balanced Pluang order activity, COIN at USD 173.26 down 5.74% with 72% sell orders, and CRCL at USD 82.24 down 5.44% with 63% buy orders and a typical hold time of 3 days.
Changan Automobile announced new partnerships covering seven European markets and launched its "with U" service program at Mondial de l’Auto 2026. This marks a shift from market entry to building a local ecosystem including manufacturing, sales, serv...
At the 2026 Mondial de l’Auto, Changan Automobile signed letters of intent with eight companies across seven European markets and launched its "with U" service program. This marks a strategic move to build a strong local ecosystem combining manufactu...
Northland Power Inc. announced it will release its third quarter 2026 financial results after market close on November 12, 2026. The company will host an earnings call and webcast on November 13 at 9:00 a.m. ET, providing investors an opportunity to ...
Several daily leveraged ETFs tied to tech and crypto-related stocks dropped sharply, with declines over 20%. Notable falls include GraniteShares 2x Long NBIS Daily ETF down 24.5% and Leverage Shares 2x Long CRWV Daily ETF down 23.9%. These ETFs aim t...
Recent biotech IPOs Iambic Therapeutics and City Therapeutics saw significant price jumps, rising 25.9% and 22.2% respectively after their market debuts, raising substantial capital. Inverse leveraged ETFs SMCZ and SMST also gained sharply as their u...
